Remsima is an anti-inflammatory drug that contains the active substance infliximab.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Remicade Biosimilar industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
100mg/10ml
500mg/50ml
Market Segment by Product Application
Blood Disorders
Oncology Diseases
Finally, the report provides detailed profile and data information analysis of leading company.
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Remicade Biosimilar consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Remicade Biosimilar market by identifying its various subsegments.
3.Focuses on the key global Remicade Biosimilar manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Remicade Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Remicade Biosimilar submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Remicade Biosimilar Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Remicade Biosimilar Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Remicade Biosimilar Segment by Type
2.1.1 100mg/10ml
2.1.2 500mg/50ml
2.2 Market Analysis by Application
2.2.1 Blood Disorders
2.2.2 Oncology Diseases
2.3 Global Remicade Biosimilar Market Comparison by Regions (2017-2027)
2.3.1 Global Remicade Biosimilar Market Size (2017-2027)
2.3.2 North America Remicade Biosimilar Status and Prospect (2017-2027)
2.3.3 Europe Remicade Biosimilar Status and Prospect (2017-2027)
2.3.4 China Remicade Biosimilar Status and Prospect (2017-2027)
2.3.5 Japan Remicade Biosimilar Status and Prospect (2017-2027)
2.3.6 Southeast Asia Remicade Biosimilar Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Remicade Biosimilar Industry Impact
2.5.1 Remicade Biosimilar Business Impact Assessment - Covid-19
2.5.2 Market Trends and Remicade Biosimilar Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Remicade Biosimilar Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Remicade Biosimilar Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Remicade Biosimilar Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Remicade Biosimilar Manufacturer Market Share
3.5 Top 10 Remicade Biosimilar Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Remicade Biosimilar Market
3.7 Key Manufacturers Remicade Biosimilar Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Remicade Biosimilar Industry Key Manufacturers
4.1 Synthon Pharmaceuticals
4.1.1 Compan Detail
4.1.2 Synthon Pharmaceuticals Remicade Biosimilar Product Introduction, Application and Specification
4.1.3 Synthon Pharmaceuticals 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Synthon Pharmaceuticals News
4.2 LG Life Sciences
4.2.1 Compan Detail
4.2.2 LG Life Sciences Remicade Biosimilar Product Introduction, Application and Specification
4.2.3 LG Life Sciences Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Synthon Pharmaceuticals News
4.3 Novartis (Sandoz)
4.3.1 Compan Detail
4.3.2 Novartis (Sandoz) Remicade Biosimilar Product Introduction, Application and Specification
4.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis (Sandoz) News
4.4 Celltrion
4.4.1 Compan Detail
4.4.2 Celltrion Remicade Biosimilar Product Introduction, Application and Specification
4.4.3 Celltrion Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Celltrion News
4.5 Biocon
4.5.1 Compan Detail
4.5.2 Celltrion Remicade Biosimilar Product Introduction, Application and Specification
4.5.3 Biocon Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Biocon News
4.6 Hospira
4.6.1 Compan Detail
4.6.2 Hospira Remicade Biosimilar Product Introduction, Application and Specification
4.6.3 Hospira Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Hospira News
4.7 Merck Serono (Merck Group)
4.7.1 Compan Detail
4.7.2 Merck Serono (Merck Group) Remicade Biosimilar Product Introduction, Application and Specification
4.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Biogen idec Inc.
4.8.1 Compan Detail
4.8.2 Biogen idec Inc. Remicade Biosimilar Product Introduction, Application and Specification
4.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Biogen idec Inc. News
4.9 Genentech (Roche Group)
4.9.1 Compan Detail
4.9.2 Genentech (Roche Group) Remicade Biosimilar Product Introduction, Application and Specification
4.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Genentech (Roche Group) News
5 Global Remicade Biosimilar Market Segment by Big Type
5.1 Global Remicade Biosimilar Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Remicade Biosimilar Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Remicade Biosimilar Revenue and Market Share by Big Type (2017-2022)
5.2 100mg/10ml Sales Growth Rate and Price
5.2.1 Global 100mg/10ml Sales Growth Rate (2017-2022)
5.2.2 Global 100mg/10ml Price (2017-2022)
5.3 500mg/50ml Sales Growth Rate and Price
5.3.1 Global 500mg/50ml Sales Growth Rate (2017-2022)
5.3.2 Global 500mg/50ml Price (2017-2022)
6 Global Remicade Biosimilar Market Segment by Big Application
6.1 Global Remicade Biosimilar Sales Market Share by Big Application (2017-2022)
6.2 Blood Disorders Sales Growth Rate (2017-2022)
6.3 Oncology Diseases Sales Growth Rate (2017-2022)
7 Global Remicade Biosimilar Forecast
7.1 Global Remicade Biosimilar Revenue, Sales and Growth Rate (2022-2027)
7.2 Remicade Biosimilar Market Forecast by Regions (2022-2027)
7.2.1 North America Remicade Biosimilar Market Forecast (2022-2027)
7.2.2 Europe Remicade Biosimilar Market Forecast (2022-2027)
7.2.3 China Remicade Biosimilar Market Forecast (2022-2027)
7.2.4 Japan Remicade Biosimilar Market Forecast (2022-2027)
7.2.5 Southeast Asia Remicade Biosimilar Market Forecast (2022-2027)
7.2.6 Other Regions Remicade Biosimilar Market Forecast (2022-2027)
7.3 Remicade Biosimilar Market Forecast by Type (2022-2027)
7.3.1 Global Remicade Biosimilar Sales Forecast by Type (2022-2027)
7.3.2 Global Remicade Biosimilar Market Share Forecast by Type (2022-2027)
7.4 Remicade Biosimilar Market Forecast by Application (2022-2027)
7.4.1 Global Remicade Biosimilar Sales Forecast by Application (2022-2027)
7.4.2 Global Remicade Biosimilar Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Remicade Biosimilar Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Remicade Biosimilar Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Remicade Biosimilar
Figure Market Concentration Ratio and Market Maturity Analysis of Remicade Biosimilar
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Remicade Biosimilar Market Size by Big Type
Figure Global Market Share of Remicade Biosimilar by Big Type in 2021
Figure 100mg/10ml Picture (2017-2022)
Global Remicade Biosimilar Market Size by Big Application
Table Global Remicade Biosimilar Market Size by Application
Figure Global Remicade Biosimilar Market Share by Big Application in 2021
Figure Blood Disorders Picture
Figure Oncology Diseases Picture
Table Global Remicade Biosimilar Comparison by Regions (M USD) (2017-2027?
Figure Global Remicade Biosimilar Market Size (Million US$) (2017-2027)
Figure North America Remicade Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Remicade Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure China Remicade Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Remicade Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Remicade Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Remicade Biosimilar Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Remicade Biosimilar Sales by Manufacturer (2017-2022)
Figure Global Remicade Biosimilar Sales Market Share by Manufacturer in 2021
Table Global Remicade Biosimilar Revenue by Manufacturer (2017-2022)
Figure Global Remicade Biosimilar Revenue Market Share by Manufacturer in 2021
Table Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Remicade Biosimilar Market
Table Key Manufacturers Remicade Biosimilar Product Type
Table Mergers & Acquisitions Planning
Table Synthon Pharmaceuticals Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Synthon Pharmaceuticals
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table LG Life Sciences Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of LG Life Sciences
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table LG Life Sciences Recent Development
Table Novartis (Sandoz) Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Novartis (Sandoz)
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis (Sandoz) Main Business
Table Novartis (Sandoz) Recent Development
Table Celltrion Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Celltrion
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celltrion Main Business
Table Celltrion Recent Development
Table Celltrion Main Business
Table Celltrion Recent Development
Table Biocon Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Biocon
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocon Main Business
Table Biocon Recent Development
Table Hospira Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Hospira
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hospira Main Business
Table Hospira Recent Development
Table Merck Serono (Merck Group) Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Merck Serono (Merck Group)
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Serono (Merck Group) Main Business
Table Merck Serono (Merck Group) Recent Development
Table Biogen idec Inc. Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Biogen idec Inc.
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biogen idec Inc. Main Business
Table Biogen idec Inc. Recent Development
Table Genentech (Roche Group) Company Profile
Table Remicade Biosimilar Product Introduction, Application and Specification of Genentech (Roche Group)
Table Remicade Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genentech (Roche Group) Main Business
Table Genentech (Roche Group) Recent Development
Figure Global Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure Global Remicade Biosimilar Revenue and Growth Rate (2017-2022)
Table Global Remicade Biosimilar Sales by Regions (2017-2022)
Figure Global Remicade Biosimilar Sales Market Share by Regions in 2021
Table Global Remicade Biosimilar Revenue by Regions (2017-2022)
Figure Global Remicade Biosimilar Revenue Market Share by Regions in 2021
Figure North America Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure Europe Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure China Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure Japan Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure Southeast Asia Remicade Biosimilar Sales and Growth Rate (2017-2022)
Figure Other Regions Remicade Biosimilar Sales and Growth Rate (2017-2022)
Table Global Remicade Biosimilar Sales by Big Type (2017-2022)
Table Global Remicade Biosimilar Sales Market Share by Big Type (2017-2022)
Figure Global Remicade Biosimilar Sales Market Share by Big Type in 2019
Table Global Remicade Biosimilar Revenue by Big Type (2017-2022)
Table Global Remicade Biosimilar Revenue Market Share by Big Type (2017-2022)
Table Global Remicade Biosimilar Revenue Market Share by Big Type in 2019
Figure Global 100mg/10ml Sales Growth Rate (2017-2022)
Figure Global 100mg/10ml Price (2017-2022)
Figure Global 500mg/50ml Sales Growth Rate (2017-2022)
Table Global Remicade Biosimilar Sales by Big Application (2017-2022)
Table Global Remicade Biosimilar Sales Market Share by Big Application (2017-2022)
Figure Global Remicade Biosimilar Sales Market Share by Big Application in 2019
Figure Global Blood Disorders Sales Growth Rate (2017-2022)
Figure Global Oncology Diseases Sales Growth Rate (2017-2022)
Figure Global Remicade Biosimilar Sales and Growth Rate (2022-2027)
Figure Global Remicade Biosimilar Revenue and Growth Rate (2022-2027)
Table Global Remicade Biosimilar Sales Forecast by Regions (2022-2027)
Table Global Remicade Biosimilar Market Share Forecast by Regions (2022-2027)
Figure North America Sales Remicade Biosimilar Market Forecast (2022-2027)
Figure Europe Sales Remicade Biosimilar Market Forecast (2022-2027)
Figure China Sales Remicade Biosimilar Market Forecast (2022-2027)
Figure Japan Sales Remicade Biosimilar Market Forecast (2022-2027)
Figure Southeast Asia Sales Remicade Biosimilar Market Forecast (2022-2027)
Figure Other Regions Sales Remicade Biosimilar Market Forecast (2022-2027)
Table Global Remicade Biosimilar Sales Forecast by Type (2022-2027)
Table Global Remicade Biosimilar Market Share Forecast by Type (2022-2027)
Table Global Remicade Biosimilar Sales Forecast by Application (2022-2027)
Table Global Remicade Biosimilar Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remicade Biosimilar
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Remicade Biosimilar Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Remicade Biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Remicade Biosimilar Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Remicade Biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Remicade Biosimilar Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Remicade Biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Remicade Biosimilar Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Remicade Biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)